All Stories

  1. A simplified MALDI-TOF MS method for rapid fluconazole susceptibility testing in Candida species

    Article • Journal of Medical Microbiology, June 2026, Society for General Microbiology

    Angelica Schreiber

  2. Evidence that increased azole persistence and stress resistance precede the in vivo evolution of azole resistance in Aspergillus fumigatus

    Article • Microbiology Spectrum, March 2026, ASM Journals

    Angelica Schreiber

  3. Microbiological contamination and mycotoxin detection in guarana integument: addressing safety concerns in guarana agro-industrial co-products

    Article • Food Science and Technology, October 2025, Zeppelini Editorial e Comunicacao

    Angelica Schreiber

  4. Presence of multidrug-resistant bacteria on ready-to-use laryngoscope blades and handles: A cross-sectional study

    Article • American Journal of Infection Control, April 2025, Elsevier

    Angelica Schreiber

  5. Enhancing Antifungal Drug Discovery Through Co-Culture with Antarctic Streptomyces albidoflavus Strain CBMAI 1855

    Article • International Journal of Molecular Sciences, November 2024, MDPI AG

    Angelica Schreiber

  6. Evolutionary origin and population diversity of a cryptic hybrid pathogen

    Article • Nature Communications, September 2024, Springer Science + Business Media

    Angelica Schreiber

  7. Spore-forming bacteria in gelatin: Characterization, identification by 16S rRNA and MALDI-TOF mass spectrometry (MS), and presence of heat resistance and virulence genes

    Article • International Journal of Food Microbiology, September 2024, Elsevier

    Angelica Schreiber

  8. Long-lasting effects of control measures on trends in incidence in neonatal late-onset sepsis due to multiresistant bacteria in a Brazilian neonatal unit

    Article • American Journal of Infection Control, August 2024, Elsevier

    Angelica Schreiber

  9. Cytocompatibility and Antibiofilm Activity of Calcium Hydroxide Mixed with Cyperus articulatus Essential Oil and Bio-C Temp Bioceramic Intracanal Medicament

    Article • Antibiotics, July 2024, MDPI AG

    Angelica Schreiber

  10. Insights into Aspergillus fumigatus Colonization in Cystic Fibrosis and Cross-Transmission between Patients and Hospital Environments

    Article • Journal of Fungi, June 2024, MDPI AG

    Angelica Schreiber

  11. Challenging fungal infections in cystic fibrosis: a case of mixed Aspergillus species infection and antifungal combination testing

    Article • Access Microbiology, April 2024, Society for General Microbiology

    Angelica Schreiber

  12. Challenging fungal infections in cystic fibrosis: a case of mixed Aspergillus species infection and antifungal combination testing

    Article • February 2024, Society for General Microbiology

    Angelica Schreiber

  13. Uncovering a Novel cyp51A Mutation and Antifungal Resistance in Aspergillus fumigatus through Culture Collection Screening

    Article • Journal of Fungi, February 2024, MDPI AG

    Angelica Schreiber

  14. Hemograms and serial hemogram-derived ratios in survivors and non-survivors of COVID-19 in Campinas, Brazil

    Article • Hematology Transfusion and Cell Therapy, January 2024, Elsevier

    Angelica Schreiber

  15. Misleading subcutaneous mycosis: a case report of subsequent clinical mycetoma-like and histological chromoblastomycosis-like lesions

    Article • Revista do Instituto de Medicina Tropical de São Paulo, January 2024, FapUNIFESP (SciELO)

    Angelica Schreiber

  16. Challenging fungal infections in cystic fibrosis: a case of mixed Aspergillus species infection and antifungal combination testing

    Article • December 2023, Society for General Microbiology

    Angelica Schreiber

  17. Matrix-assisted laser desorption/ionisation-time of flight mass spectrometry azole susceptibility assessment in Candida and Aspergillus species

    Article • Memórias do Instituto Oswaldo Cruz, January 2023, FapUNIFESP (SciELO)

    Angelica Schreiber

  18. Increased Serum Mir-150-3p Expression Is Associated with Radiological Lung Injury Improvement in Patients with COVID-19

    Article • Viruses, June 2022, MDPI AG

    Angelica Schreiber

  19. Selection of Aspergillus fumigatus isolates carrying the G448S substitution in CYP51A gene after long-term treatment with voriconazole in an immunocompromised patient

    Article • Medical Mycology Case Reports, June 2022, Elsevier

    Angelica Schreiber

  20. COVID-19 and invasive fungal coinfections: A case series at a Brazilian referral hospital

    Article • Journal de Mycologie Médicale, December 2021, Elsevier

    Angelica Schreiber

  21. Identification of SARS-CoV-2 on the ocular surface in a cohort of COVID-19 patients from Brazil

    Article • Experimental Biology and Medicine, July 2021, Frontiers

    Angelica Schreiber

  22. Respiratory Viral Shedding in Healthcare Workers Reinfected with SARS-CoV-2, Brazil, 2020

    Article • Emerging Infectious Diseases, January 2021, Centers for Disease Control and Prevention (CDC)

    Angelica Schreiber

  23. Evolution and epidemic spread of SARS-CoV-2 in Brazil

    Article • Science, July 2020, American Association for the Advancement of Science

    Angelica Schreiber, Dr. Renan Pedra de Souza

  24. Evolution and epidemic spread of SARS-CoV-2 in Brazil

    Article • June 2020, Cold Spring Harbor Laboratory Press

    Angelica Schreiber

  25. Lysine acetylation as drug target in fungi: an underexplored potential in Aspergillus spp.

    Article • Brazilian Journal of Microbiology, March 2020, Springer Science + Business Media

    Angelica Schreiber

  26. Mycetoma-like phaeohyphomycosis treated with terbinafine

    Article • IDCases, January 2020, Elsevier

    Angelica Schreiber

  27. Visible DNA microarray and loop-mediated isothermal amplification (LAMP) for the identification of Cryptococcus species recovered from culture medium and cerebrospinal fluid of patients with meningitis

    Article • Brazilian Journal of Medical and Biological Research, January 2020, FapUNIFESP (SciELO)

    Angelica Schreiber

  28. Aspergillus fumigatus Clinical Isolates Carrying CYP51A with TR34/L98H/S297T/F495I Substitutions Detected after Four-Year Retrospective Azole Resistance Screening in Brazil

    Article • Antimicrobial Agents and Chemotherapy, December 2019, ASM Journals

    Angelica Schreiber

  29. Testes para identificação e diferenciação de espécies do Complexo Cryptococcus neoformans/gattii: validação do processo para produção industrial

    Article • November 2019, Universidade Estadual de Campinas

    Angelica Schreiber

  30. Avaliação de fatores predisponentes relacionados a pacientes dos quais foram obtidos um ou mais isolados seqüenciais de Aspergillus fumigatus considerados resistentes a anfotericina B

    Article • January 2019, Universidade Estadual de Campinas

    Angelica Schreiber

  31. Airborne transmission of invasive fusariosis in patients with hematologic malignancies

    Article • PLOS One, April 2018, PLOS

    Angelica Schreiber

  32. Surveillance for azoles resistance in Aspergillus spp. highlights a high number of amphotericin B-resistant isolates

    Article • Mycoses, March 2018, Wiley

    Angelica Schreiber

  33. Visible DNA Microarray System as an Adjunctive Molecular Test in Identification of Pathogenic Fungi Directly from a Blood Culture Bottle

    Article • Journal of Clinical Microbiology, March 2018, ASM Journals

    Angelica Schreiber

  34. Serum markers as an aid in the diagnosis of pulmonary fungal infections in AIDS patients

    Article • The Brazilian Journal of Infectious Diseases, November 2017, Elsevier

    Angelica Schreiber

  35. Detection of Pneumocystis jirovecii by nested PCR in HIV-negative patients with pulmonary disease

    Article • Revista Iberoamericana de Micología, April 2017, Elsevier

    Angelica Schreiber

  36. Comparison of DNA Microarray, Loop-Mediated Isothermal Amplification (LAMP) and Real-Time PCR with DNA Sequencing for Identification of Fusarium spp. Obtained from Patients with Hematologic Malignancies

    Article • Mycopathologia, March 2017, Springer Science + Business Media

    Angelica Schreiber

  37. Resistance Surveillance in Candida albicans: A Five-Year Antifungal Susceptibility Evaluation in a Brazilian University Hospital

    Article • PLOS One, July 2016, PLOS

    Angelica Schreiber

  38. Severe Paracoccidioidomycosis in a 14-Year-Old Boy

    Article • Mycopathologia, June 2016, Springer Science + Business Media

    Angelica Schreiber

  39. Evaluation of antifungal combination againstCryptococcusspp.

    Article • Mycoses, May 2016, Wiley

    Angelica Schreiber

  40. Influence of the Culture Medium in Dose-Response Effect of the Chlorhexidine onStreptococcus mutansBiofilms

    Article • Scientifica, January 2016, Hindawi Publishing Corporation

    Angelica Schreiber

  41. Mortality related to candidemia and risk factors associated with non-Candida albicans

    Article • Infectious Diseases, August 2015, Taylor & Francis

    Angelica Schreiber

  42. Isolation and Drug Susceptibility of Candida parapsilosis Sensu Lato and other Species of C. parapsilosis Complex from Patients with Blood Stream Infections and Proposal of a Novel LAMP Identification Method for the Species

    Article • Mycopathologia, December 2014, Springer Science + Business Media

    Angelica Schreiber

  43. Fusarium napiforme systemic infection: case report with molecular characterization and antifungal susceptibility tests

    Article • SpringerPlus, August 2014, Springer Science + Business Media

    Angelica Schreiber

  44. Development of cycling probe-based real-time PCR system to detect Fusarium species and Fusarium solani species complex (FSSC)

    Article • International Journal of Medical Microbiology, May 2014, Elsevier

    Angelica Schreiber

  45. Visual Analysis of DNA Microarray Data for Accurate Molecular Identification of Non-albicans Candida Isolates from Patients with Candidemia Episodes

    Article • Journal of Clinical Microbiology, June 2013, ASM Journals

    Angelica Schreiber

  46. Is the incidence of candidemia caused byCandida glabrataincreasing in Brazil? Five-year surveillance ofCandidabloodstream infection in a university reference hospital in southeast Brazil

    Article • Medical Mycology, April 2013, Oxford University Press (OUP)

    Angelica Schreiber

  47. Susceptibility testing of terbinafine alone and in combination with amphotericin B, itraconazole, or voriconazole against conidia and hyphae of dematiaceous molds

    Article • Diagnostic Microbiology and Infectious Disease, December 2011, Elsevier

    Angelica Schreiber

  48. In VitroEvaluation of the Type of Interaction Obtained by the Combination of Terbinafine and Itraconazole, Voriconazole, or Amphotericin B against Dematiaceous Molds

    Article • Antimicrobial Agents and Chemotherapy, June 2011, ASM Journals

    Angelica Schreiber

  49. Standardization of Hyphal Growth Inhibition Rate as a Means of Evaluating Microsporum spp. in vitro Susceptibility to Terbinafine, Griseofulvin, and Ciclopiroxolamine

    Article • Mycopathologia, May 2011, Springer Science + Business Media

    Angelica Schreiber

  50. Expression of activation and cytotoxic molecules by peripheral blood lymphocytes of patients with paracoccidioidomycosis

    Article • Medical Mycology, September 2010, Oxford University Press (OUP)

    Angelica Schreiber

  51. Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation

    Article • Transplant Infectious Disease, April 2009, Wiley

    Angelica Schreiber

  52. Preanalytical conditions for broth microdilution antifungal susceptibility of Microsporum spp.

    Article • Mycoses, July 2008, Wiley

    Angelica Schreiber

  53. Evaluation of the inhibitory effect of amphotericin B on the apical growth ofF. solaniusing the BioCell-Tracer®System

    Article • Mycoses, March 2007, Wiley

    Angelica Schreiber

  54. Diagnosis of candidemia by polymerase chain reaction and blood culture: prospective study in a high-risk population and identification of variables associated with development of candidemia

    Article • European Journal of Clinical Microbiology & Infectious Diseases, November 2005, Springer Science + Business Media

    Angelica Schreiber

  55. Evaluation of Fusarium solani Hyphae and Conidia Susceptibility to Amphotericin B and Itraconazole: Study of a Clinical Case

    Article • Mycopathologia, November 2005, Springer Science + Business Media

    Angelica Schreiber

  56. Antifungal Susceptibility and Pathogenic Potential of Environmental Isolated Filamentous Fungi Compared with Colonizing Agents in Immunocompromised Patients

    Article • Mycopathologia, September 2005, Springer Science + Business Media

    Angelica Schreiber

  57. Respiration, oxidative phosphorylation, and uncoupling protein in Candida albicans

    Article • Brazilian Journal of Medical and Biological Research, October 2004, FapUNIFESP (SciELO)

    Angelica Schreiber

  58. Phaeohyphomycosis Caused byChaetomium Globosumin an Allogeneic Bone Marrow Transplant Recipient

    Article • Mycopathologia, January 2003, Springer Science + Business Media

    Angelica Schreiber

  59. Respiratory chain network in mitochondria ofCandida parapsilosis: ADP/O appraisal of the multiple electron pathways

    Article • FEBS Letters, November 2001, Wiley

    Angelica Schreiber

  60. Ca2+transport into an intracellular acidic compartment ofCandida parapsilosis

    Article • FEBS Letters, June 2001, Wiley

    Angelica Schreiber

  61. Trichosporon species infection in bone marrow transplanted patients

    Article • Diagnostic Microbiology and Infectious Disease, March 2001, Elsevier

    Angelica Schreiber

  62. First evidence and characterization of an uncoupling protein in fungi kingdom: CpUCP of Candida parapsilosis

    Article • FEBS Letters, February 2000, Wiley

    Angelica Schreiber

  63. Candida parapsilosis Fungemia Associated with Implantable and Semi-Implantable Central Venous Catheters and the Hands of Healthcare Workers

    Article • Diagnostic Microbiology and Infectious Disease, April 1998, Elsevier

    Angelica Schreiber